#India #Chennai #Co-Diagnostics #Tuberculosis #CoSara

CoSara Diagnostics Joins the Advanced TB Diagnostics Course in Chennai

In a significant move to bolster tuberculosis (TB) detection efforts across the South-East Asian Region, CoSara Diagnostics Pvt. Ltd., the joint venture of Co-Diagnostics, Inc., has been invited to partake in the 2nd Advanced TB Diagnostics Course. This important event is set to unfold from December 15-19, 2025, at the prestigious ICMR–National Institute for Research in Tuberculosis (NIRT) in Chennai, India.

Addressing Tuberculosis Challenges

The Advanced TB Diagnostics Course is being hosted by ICMR-NIRT in collaboration with the McGill International TB Centre and various other global health organizations. The workshop is designed to provide capacity-building tools for nations within the South-East Asian Region confronting the ongoing challenges posed by tuberculosis.

With TB being a leading infectious disease globally, this workshop aims to convene key stakeholders, including TB program leads, diagnostics innovators, and industry partners, to foster dialogue and collaboration aimed at improving detection techniques and research methodologies. The program will focus on essential aspects of tuberculosis including diagnostics, and implementation challenges.

Workshop Highlights

The format of the workshop is comprehensive, covering the entire diagnostics value chain—from new technologies that are being developed to practical strategies for addressing the current gaps in TB detection across participating countries. Attendees can expect sessions that delve into cost-effective modeling and evidence-based policy development tailored to improve responses to tuberculosis.

Notably, the five-day event will include presentations and engaging panel discussions led by esteemed national and international faculty. Experts from globally recognized entities, such as the World Health Organization (WHO), The Gates Foundation, and FIND, among elite institutions like Boston University and India’s central TB establishments, will contribute their insights and expertise.

In addition to the informative sessions, industry innovators will have an opportunity to showcase cutting-edge diagnostic solutions through technology pitches, highlighting advancements that may revolutionize TB detection and management.

Co-Diagnostics Overview

Co-Diagnostics, Inc., based in Utah, is at the forefront of molecular diagnostics, focusing on the design, manufacture, and marketing of advanced diagnostic technologies. Leveraging a patented platform, Co-Diagnostics specializes in nucleic acid detection methodologies, shaping the future of medical testing. The company has also developed its Co-Dx PCR at-home and point-of-care platform, currently pending regulatory review, aimed at identifying specific genetic markers applicable not only to infectious diseases but a wider array of health applications.

The participation of CoSara in this significant workshop underlines the commitment of Co-Diagnostics to tackle pressing health challenges through innovation and collaboration, particularly in the fight against tuberculosis which continues to affect millions worldwide. This initiative also reflects a broader dedication to enhancing public health frameworks in under-resourced regions.

Conclusion

The 2nd Advanced TB Diagnostics Course in Chennai represents a pivotal opportunity for CoSara and its partners, as they come together to shape the future landscape of tuberculosis diagnostics. By fostering collaboration and sparking innovation, participants hope to bridge the existing gaps in TB detection and enhance the overall efficacy of TB management strategies in the South-East Asian Region.